Acadian Asset Management’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
Other funds holding IDYA
BBA
LGM
Acadian Asset Management's IDYA Position: Q1 2026 in Review
Acadian Asset Management sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 1,430 shares — an estimated $49K sold.
Acadian Asset Management first reported a position in IDYA in Q3 2020 and held it in 12 quarters. The position peaked at $8.64M in Q3 2021. 254 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.
- Acadian Asset Management reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
- Acadian Asset Management sold 1,430 IDEAYA Biosciences shares in Q1 2026, an estimated $49K.
- Acadian Asset Management first reported a position in IDEAYA Biosciences in Q3 2020 and held it in 12 quarters.
- Acadian Asset Management's IDEAYA Biosciences position peaked at $8.64M in Q3 2021.
- 254 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.
Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.